Inotiv, Inc. Provides Business Update and Select Preliminary Fiscal Year 2022 Financi

[admin]

Delays Release of Full Financial Results for the Fourth Quarter and Fiscal Year Ended September 30, 2022WEST LAFAYETTE, Ind., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, announced today that it will delay the release and conference call related to its financial